Patents-Review.com
ClassID:

114993 ⎘

C12Y203/01048 - CPC Classification

Classification description:

Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1) Histone acetyltransferase (2.3.1.48)

Recent Application in this class:
#1
20260146241
2026-05-28

Engineered CasPhi2 Nucleases

 #2
20260043058
2026-02-12

SHC ENZYMES AND ENZYME VARIANTS

 #3
20250257341
2025-08-14

COMPOSITIONS AND METHODS FOR EPIGENOME EDITING

 #4
20230046656
2023-02-16

CREBBP RELATED CANCER THERAPY

 #5
20220348893
2022-11-03

METHODS AND COMPOSITIONS FOR MODULATING FRATAXIN EXPRESSION AND TREATING FRIEDRICH'S ATAXIA

 #6
20220315967
2022-10-06

METHODS FOR PRODUCING D-TRYPTOPHAN AND SUBSTITUTED D-TRYPTOPHANS

 #7
20220098561
2022-03-31

Compositions and methods for epigenome editing

 #8
20220090142
2022-03-24

TRANSPOSASE WITH ENHANCED INSERTION SITE SELECTION PROPERTIES

 #9
20210355465
2021-11-18

Engineered CRISPR-Cas9 Nucleases

 #10
20200385695
2020-12-10

Compositions and methods for epigenome editing

 #11
20200149024
2020-05-14

Engineered CRISPR-Cas9 nucleases

 #12
20190256827
2019-08-22

EPIGENOME EDITING SYSTEMS AND METHODS

 #13
20190194633
2019-06-27

COMPOSITIONS, SYSTEMS AND METHODS FOR PROGRAMMING IMMUNE CELL FUNCTION THROUGH TARGETED GENE REGULATION

 #14
20180216088
2018-08-02

Engineered CRISPR-Cas9 nucleases

 #15
20180023064
2018-01-25

Compositions and methods for epigenome editing

 #16
20150079657
2015-03-19

Targeted histone acetylation

 #17
20130345267
2013-12-26

Methods and compositions for modulating P300/CBP activity

 #18
20100216853
2010-08-26

Methods and compositions for modulating P300/CBP activity

 #19
20090253769
2009-10-08

Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders

 #20
20060040884
2006-02-23

Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition